Results 81 to 90 of about 10,278,879 (215)
D-penicillamine is a thiol drug mainly used for Wilson’s disease, rheumatoid arthritis and cystinuria. Adverse effects during normal use of the drug are frequent and may include skin lesions.
SARACINO, MARIA ADDOLORATA +7 more
core +1 more source
Introduction: Wilson disease (WD) is a rare metabolic disorder of copper metabolism, requiring life-long therapy, usually with D-penicillamine or trientine. This review compares their clinical effectiveness and safety.
Hafiz Muhammad Ehsan Arshad +5 more
doaj +1 more source
Crystal structure of S,N-dibenzyl-d-penicillamine monohydrate
In the asymmetric unit of the title compound, C19H23NO2S·H2O, there are two independent organic molecules and two water molecules. Both organic molecules exist as the zwitterionic form.
Nobuto Yoshinari, Takumi Konno
doaj +1 more source
Acute hypersensitivity pneumonitis is not a known side effect of D-penicillamine. Also, there are only a few reports of cholestatic hepatitis caused by this drug.
Malaviya, A. N. +4 more
core +1 more source
In this work, cytotoxicity and cellular impedance response was compared for CdSe/ZnS core/shell quantum dots (QDs) with positively charged cysteamine–QDs, negatively charged dihydrolipoic acid–QDs and zwitterionic D-penicillamine–QDs exposed to canine ...
Vladimir V. Breus +4 more
doaj +1 more source
Osteoporosis is a common and important feature of rheumatoid disease which can be further influenced by the treatment admiflistered. o-penicillamine. a lathyritic agent.
Schorn, D.
core
Objective: To evaluate the efficacy of oral d-penicillamine therapy in children with high blood lead concentrations. Design: A prospective, uncontrolled study.
Matitiahu Lifshitz, Jacov Levy
core +1 more source
Evaluation of vitamin B6 supplementation in Wilson's disease patients treated with D-penicillamine. [PDF]
Mbala J +4 more
europepmc +1 more source
WILSON'S DISEASE IN CHILDREN, REPORT OF 25 CASES [PDF]
We conducted a retrospective study of 25 cases (15 boys and 12 girls) of Wilson's disease(Hepatolenticular degeneration)spanning a period of 8 years. Age at the time of diagnosis ranged between 3-17 years. The f ollowing clinical forms were observed:
Y. AGHIGHI, R. AFTENDELIANS
doaj

